Q2 2026 Holdings
Filed 2026-08-11 | 463 holdings | $429.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $379.1K | 6,281 | 0.1% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $381.1K | 125,363 | 0.1% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $381.2K | 103,872 | 0.1% |
| Alumis Inc(ALMS) | COM | 022307102 | $381.3K | 13,549 | 0.1% |
| Sixth Street Specialty Lendi(TSLX) | COM | 83012A109 | $381.7K | 22,230 | 0.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $381.7K | 9,395 | 0.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $382.6K | 9,885 | 0.1% |
| Savara Inc(SVRA) | COM | 805111101 | $383.2K | 62,205 | 0.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $383.3K | 27,086 | 0.1% |
| MSC Income Fund Inc(MSIF) | COM | 55374X208 | $384.3K | 33,217 | 0.1% |
| Capital Southwest Corp(CSWC) | COM | 140501107 | $384.4K | 16,171 | 0.1% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $384.7K | 5,510 | 0.1% |
| Celcuity Inc(CELC) | COM | 15102K100 | $386.6K | 3,695 | 0.1% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $386.9K | 11,272 | 0.1% |
| Achieve Life Science Inc(ACHV) | COM | 004468500 | $387.1K | 59,275 | 0.1% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $387.2K | 12,123 | 0.1% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $387.2K | 38,002 | 0.1% |
| BlackRock Debt Strategies FD(DSU) | COM NEW | 09255R202 | $387.3K | 39,931 | 0.1% |
| Gladstone Cap Corp(GLAD) | COM NEW | 376535878 | $388.0K | 19,977 | 0.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $388.3K | 39,660 | 0.1% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $388.7K | 3,987 | 0.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $389.4K | 10,464 | 0.1% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $390.2K | 57,303 | 0.1% |
| CG Oncology Inc(CGON) | COM | 156944100 | $390.3K | 5,493 | 0.1% |
| Eaton Vance SR Income TR(EVF) | SH BEN INT | 27826S103 | $390.5K | 78,410 | 0.1% |
| First TR SR Fltg Rate Income(FCT) | COM | 33733U108 | $390.7K | 40,444 | 0.1% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $391.6K | 14,251 | 0.1% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $393.7K | 38,224 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $393.9K | 5,835 | 0.1% |
| Barings BDC Inc(BBDC) | COM | 06759L103 | $394.2K | 46,262 | 0.1% |
| Spyglass Pharma Inc(SGP) | COM SHS | 85220G109 | $395.0K | 17,744 | 0.1% |
| Annexon Inc(ANNX) | COM | 03589W102 | $396.7K | 69,468 | 0.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $398.3K | 2,127 | 0.1% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $399.2K | 38,721 | 0.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $399.5K | 17,988 | 0.1% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $400.7K | 9,109 | 0.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $400.7K | 6,894 | 0.1% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $402.2K | 15,239 | 0.1% |
| Golub Cap BDC Inc(GBDC) | COM | 38173M102 | $402.6K | 31,259 | 0.1% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $402.8K | 22,426 | 0.1% |
| Hercules Capital Inc(HTGC) | COM | 427096508 | $403.3K | 25,577 | 0.1% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $406.0K | 13,605 | 0.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $406.9K | 118,981 | 0.1% |
| Prokidney Corp(PROK) | SHS CL A | 74291D104 | $407.0K | 199,510 | 0.1% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $407.3K | 7,406 | 0.1% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $407.6K | 108,703 | 0.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $407.9K | 36,846 | 0.1% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $409.0K | 170,415 | 0.1% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $409.1K | 7,622 | 0.1% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $409.2K | 29,504 | 0.1% |